| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. | Arthritis Rheum | 2002 | 1.72 |
| 2 | Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade. | Arthritis Rheum | 2003 | 1.17 |